Pricing Log in Create free account

HUTCHMED (China) Limited Sponsored ADR (HCM) vs Regencell Bioscience Holdings Limited (RGC)

HUTCHMED (China) Limited Sponsored ADR and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. HUTCHMED (China) Limited Sponsored ADR and Regencell Bioscience Holdings Limited are of similar size ($2.6B and $2.5B). Regencell Bioscience Holdings Limited has the higher net margin (0.00% vs −23.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, Regencell Bioscience Holdings Limited leads on 5 and HUTCHMED (China) Limited Sponsored ADR on 2.

Valuation

Metric HCM RGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m — 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.38 1.13 12.22
EV/Sales (0.13) n/m 2.87
Earnings yield (20.62%) (19.96%) (15.94%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric HCM RGC Drug Manufacturers Specialty & Generic median
Gross margin 44.40% — 53.51%
Operating margin 0.00% — 0.00%
Net margin (23.63%) 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HCM RGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 245.17% — 5.22%
EPS growth (last fiscal year) 1,090.91% (177.78%) 42.91%
Revenue growth, 5-year CAGR 19.20% — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HCM RGC Drug Manufacturers Specialty & Generic median
Debt to equity 0.07 0.00 0.04
Current ratio 5.64 10.77 2.41
Net debt to EBITDA 49.29 1.22 1.01

Dividend

Metric HCM RGC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric HCM RGC Drug Manufacturers Specialty & Generic median
Market cap 2.48b 2.61b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack